Abdelbary A. Elhissi

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Correction: Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Correction: Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Journal: Frontiers in pharmacology

Published: April 22, 2026

Safety evaluation of a ketamine-dodecyl maltoside combination using angiogenesis and embryonic development models.

Safety evaluation of a ketamine-dodecyl maltoside combination using angiogenesis and embryonic development models.

Journal: Scientific reports

Published: February 02, 2026

Novel pyridine-based chalcone analogs and triple negative breast cancer: potential therapy & molecular pathways.

Novel pyridine-based chalcone analogs and triple negative breast cancer: potential therapy & molecular pathways.

Journal: Scientific reports

Published: January 27, 2026

Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Journal: Frontiers in pharmacology

Published: January 03, 2026

RETRACTED: Khan et al. Norfloxacin Loaded Lipid Polymer Hybrid Nanoparticles for Oral Administration: Fabrication, Characterization, In Silico Modelling and Toxicity Evaluation. Pharmaceutics 2021, 13, 1632.

RETRACTED: Khan et al. Norfloxacin Loaded Lipid Polymer Hybrid Nanoparticles for Oral Administration: Fabrication, Characterization, In Silico Modelling and Toxicity Evaluation. Pharmaceutics 2021, 13, 1632.

Journal: Pharmaceutics

Published: December 02, 2025

Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions.

Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions.

Journal: Pharmaceutics

Published: August 22, 2025

Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.

Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.

Journal: Pharmaceutics

Published: June 03, 2025

Enhancing gliclazide solubility using solid dispersions with carboxymethyl chitosan and polyvinylpyrrolidone K30 as polymeric carriers.

Enhancing gliclazide solubility using solid dispersions with carboxymethyl chitosan and polyvinylpyrrolidone K30 as polymeric carriers.

Journal: Drug development and industrial pharmacy

Published: May 23, 2025

Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations.

Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations.

Journal: Frontiers in immunology

Published: May 10, 2025

Inflammation-associated drug resistance and tumor growth in TNBC.

Inflammation-associated drug resistance and tumor growth in TNBC.

Journal: Frontiers in immunology

Published: May 06, 2025

PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer.

PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 04, 2025

Development and Characterization of Novel Combinations and Compositions of Nanostructured Lipid Carrier Formulations Loaded with Trans-Resveratrol for Pulmonary Drug Delivery.

Development and Characterization of Novel Combinations and Compositions of Nanostructured Lipid Carrier Formulations Loaded with Trans-Resveratrol for Pulmonary Drug Delivery.

Journal: Pharmaceutics

Published: October 22, 2024

Showing 1-12 of 66

Last Updated: 09/26/2026